Magnet Biomedicine Selects Simplicis's Ledgertm Platform To Lead Innovation In Compound Management

(MENAFN- PR Newswire)

BOSTON, March 4, 2025 /PRNewswire/ -- Magnet Biomedicine, a biotechnology company advancing molecular glue discovery through rational selection and design, has selected Simplicis's LedgerTM platform after a rigorous evaluation process that considered several leading competitors. Simplicis's unmatched combination of innovation, adaptability, and cost-efficiency proved to be the ideal choice to support Magnet's cutting-edge research operations.

Magnet Biomedicine is recognized for its TrueGlueTM discovery platform, which leverages advancements in human biology and proteomics to develop next-generation molecular glues targeting critical unmet medical needs. Choosing Simplicis's LedgerTM platform enables Magnet to advance its mission to deliver transformative therapeutic solutions.

Strategic Decision to Partner with Simplicis

Liam Hudson, Associate Director at Magnet Biomedicine, explained the decision-making process:

"After evaluating multiple platforms, it was clear that Simplicis offered a combination of Functionality, technical knowledge and value that others could not match. LedgerTM stood out as the solution that best aligns with our operational needs and future growth.

Hudson also emphasized the importance of collaboration and innovation:

"Simplicis's pragmatic and forward-thinking approach equips us with the tools to enhance our compound management capabilities and scale efficiently."

Driving Operational Efficiency with Advanced Technology

Gina Chen, Compound Management Lead at Magnet Biomedicine, highlighted the user-centric design and adaptability of Simplicis's LedgerTM platform:

"LedgerTM delivers all the features we needed-and more-in a streamlined, user-friendly interface. Its ability to support pre-validation of requests ensures accountability and simplifies workflows across teams."

Chen also noted the impact of advanced automation on team productivity:

"With Simplicis, we've seen a significant reduction in manual tasks, allowing us to focus on the science rather than the logistics."

Integration and Flexibility as Key Differentiators

James Ralff, Research Associate at Magnet Biomedicine, praised LedgerTM seamless integration capabilities:

"LedgerTM integrates effortlessly with our existing workflows, offering intuitive tools that simplify data management and enable us to work more efficiently."

Ralff highlighted the platform's ability to handle complex workflows:

"Simplicis's capabilities empower us to mine data effectively, streamline plate mapping, and optimize our processes in ways that were previously unattainable."

Implementation and Looking Ahead

Magnet Biomedicine has already begun its transition to the LedgerTM platform, with a full go-live expected in February 2025. The implementation process includes migrating legacy systems, integrating key hardware, and training staff to leverage the platform's full potential. The partnership is expected to drive significant operational efficiencies, enhance collaboration, and provide a strong foundation for future growth.

About Magnet Biomedicine

Magnet Biomedicine is a biotechnology company advancing molecular glue discovery through rational selection and design. The company's TrueGlueTM discovery platform integrates cutting-edge science and technology to develop therapeutic solutions that address critical unmet medical needs, offering transformative potential for precision medicine.

For more information, visit magnetbio.

About Simplicis

Simplicis is a leading provider of laboratory information management systems (LIMS) designed to optimize workflows, enhance data management, and drive innovation. The LedgerTM platform is a state-of-the-art solution tailored to meet the evolving needs of the biotechnology and pharmaceutical sectors, delivering efficiency and scalability for research organizations worldwide.

For more information, visit simplicis

Media Contact:
Jennifer Franklin
Vice President of Administration & Operations
Magnet Biomedicine
[email protected]
(617) 741-0974

SOURCE Simplicis

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN04032025003732001241ID1109276138